We experienced a case of malignant hyperthermia (MH) in 6-year-old boy during anesthesia induction for strabismus surgery. It has been generally reported that sevoflurane can induce the delayed onset of MH in the absence of succinylcholine. Our case of MH was elicited after about 2-3 min of sevoflurane administration with N2O, O2 and rocuronium. However, we successfully treated the patient by early recognition of his condition and administering symptomatic treatment and dantrolene. (Korean J Anesthesiol 2010; 59: S6-S8) Key Words: Dantrolene, Malignant hyperthermia, Sevoflurane. A case of malignant hyperthermia during anesthesia induction with sevoflurane-A case report
Copyright © 2014 Michihiro Sakai et al.This is an open access article distributed under theCreative ...
Contains fulltext : 81455.pdf (publisher's version ) (Closed access)Stuve Wiedeman...
Malignant hyperthermia (MH) is a rare hypermetabolic disorder of skeletal muscles that manifests as ...
Malignant hyperthermia is a rare pharmacogenetic disorder triggered by depolarizing muscle relaxant ...
Malignant hyperthermia (MH) is a genetic syndrome characterized by hyperthermia, tachycardia, acidos...
Copyright © 2013 Frank Schuster et al.This is an open access article distributed under the Creative ...
Copyright © 2013 K. Sanem Cakar Turhan et al.This is an open access article distributed under the Cr...
Malignant hyperthermia (MH) can develop after contact with volatile anesthetics (halothane, enfluran...
Malignant hyperthermia manifests clinically as a hypermetabolic crisis when a malignant hyperthermia...
Malignant Hyperthermia (MH), is a rare emergency that happened during General Anesthesia. In Albania...
Background Malignant hyperthermia (MH), a metabolic myopathy triggered by volatile anesthetics an...
Malignant hyperthermia is a subclinical myopathy, usually triggered by anesthetics and associated wi...
Background and objectives: Malignant hyperthermia (MH) is a pharmacogenetic skeletal muscle disorder...
Background and objectives: Malignant hyperthermia (MH) is a pharmacogenetic skeletal muscle disorder...
Malignant Hyperthermia (MH) is a rare, hereditary, life-threatening disease triggered by volatile an...
Copyright © 2014 Michihiro Sakai et al.This is an open access article distributed under theCreative ...
Contains fulltext : 81455.pdf (publisher's version ) (Closed access)Stuve Wiedeman...
Malignant hyperthermia (MH) is a rare hypermetabolic disorder of skeletal muscles that manifests as ...
Malignant hyperthermia is a rare pharmacogenetic disorder triggered by depolarizing muscle relaxant ...
Malignant hyperthermia (MH) is a genetic syndrome characterized by hyperthermia, tachycardia, acidos...
Copyright © 2013 Frank Schuster et al.This is an open access article distributed under the Creative ...
Copyright © 2013 K. Sanem Cakar Turhan et al.This is an open access article distributed under the Cr...
Malignant hyperthermia (MH) can develop after contact with volatile anesthetics (halothane, enfluran...
Malignant hyperthermia manifests clinically as a hypermetabolic crisis when a malignant hyperthermia...
Malignant Hyperthermia (MH), is a rare emergency that happened during General Anesthesia. In Albania...
Background Malignant hyperthermia (MH), a metabolic myopathy triggered by volatile anesthetics an...
Malignant hyperthermia is a subclinical myopathy, usually triggered by anesthetics and associated wi...
Background and objectives: Malignant hyperthermia (MH) is a pharmacogenetic skeletal muscle disorder...
Background and objectives: Malignant hyperthermia (MH) is a pharmacogenetic skeletal muscle disorder...
Malignant Hyperthermia (MH) is a rare, hereditary, life-threatening disease triggered by volatile an...
Copyright © 2014 Michihiro Sakai et al.This is an open access article distributed under theCreative ...
Contains fulltext : 81455.pdf (publisher's version ) (Closed access)Stuve Wiedeman...
Malignant hyperthermia (MH) is a rare hypermetabolic disorder of skeletal muscles that manifests as ...